Syncom Formulations is trading 5.06% down at ₹19.12 after declining from ₹20.14 on September 9, 2026.
- No company-specific announcement, earnings update, guidance change, or regulatory action dated September 9–10 was identified.
- The latest available notice was a September 1 AGM-related filing, which does not explain the decline.
- September 9 volume was 2,540,929 shares, indicating active trading.